|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/18 | |
| A61K 38/26 | |||
| A61P 3/04 |
| (11) | Patento numeris | 2185178 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08796800.4 |
| Europos patento paraiškos padavimo data | 2008-07-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-05-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-08-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/071508 |
| Data | 2008-07-30 |
| (87) | Numeris | WO 2009/020802 |
| Data | 2009-02-12 |
| (30) | Numeris | Data | Šalis |
| 953785 P | 2007-08-03 | US |
| (72) |
COSKUN, Tamer, US
GLAESNER, Wolfgang, US
|
| (73) |
ELI LILLY AND COMPANY,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY |
| USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY |